Skip to main content
Fig. 2 | Alzheimer's Research & Therapy

Fig. 2

From: Increased levels of the synaptic proteins PSD-95, SNAP-25, and neurogranin in the cerebrospinal fluid of patients with Alzheimer’s disease

Fig. 2

CSF levels of PSD-95 (A), SNAP-25 (C), and Neurogranin (E) in healthy controls (HC) and subjects with Alzheimer’s disease (AD), non-AD neurodegenerative diseases (NeuroDegen), and neurological controls (NeuroCtrl) from cohort I. CSF levels of PSD-95 (B), SNAP-25 (D), and neurogranin (F) by diagnosis. Solid green lines represent the median of the groups and dotted green lines represent the mean. Statistical analysis to determine differences between the individual NeuroDegen and NeuroCtrl diseases (B, D, and F) was not performed due to the large number of comparisons and small sample sizes, and graphs are included to provide information on outlier status

Back to article page

Alzheimer's Research & Therapy

ISSN: 1758-9193